Marija Kuna

Marija Kuna

Auto-generated profile, based on publicly available information

Marija Kuna

Department of Pathology and Laboratory Medicine, Institute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, KS 66160

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
VSVinay Shukla
Vinay Shukla
AMAyelen Moreno-Irusta
Ayelen Moreno-Irusta
KVKaela Varberg
Kaela Varberg
MKMarija Kuna
Marija Kuna
KIKhursheed Iqbal
Khursheed Iqbal
MSMichael J. Soares
Michael J. Soares
Trophoblast stem (TS) cells have the unique capacity to differentiate into specialized cell types, including extravillous trophoblast (EVT) cells. EVT cells invade into and transform the uterus where they act to remodel the vasculature facilitating the redirection of maternal nutrients to the developing fetus. Disruptions in EVT cell development and function are at the core of pregnancy-related disease. WNT-activated signal transduction is a conserved regulator of morphogenesis of many organ systems, including the placenta. In human TS cells, activation of canonical WNT signaling is critical for maintenance of the TS cell stem state and its downregulation accompanies EVT cell differentiation. We show that aberrant WNT signaling undermines EVT cell differentiation. Notum, palmitoleoyl-protein carboxylesterase (NOTUM), a negative regulator of canonical WNT signaling, was prominently expressed in first-trimester EVT cells developing in situ and up-regulated in EVT cells derived from human TS cells. Furthermore, NOTUM was required for optimal human TS cell differentiation to EVT cells. Activation of NOTUM in EVT cells is driven, at least in part, by endothelial Per-Arnt-Sim (PAS) domain 1 (also called hypoxia-inducible factor 2 alpha). Collectively, our findings indicate that canonical Wingless-related integration site (WNT) signaling is essential for maintenance of human trophoblast cell stemness and regulation of human TS cell differentiation. Downregulation of canonical WNT signaling via the actions of NOTUM is required for optimal EVT cell differentiation.

10 January 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MKMarija Kuna
Marija Kuna
PDPramod Dhakal
Pramod Dhakal
KIKhursheed Iqbal
Khursheed Iqbal
EDEsteban M. Dominguez
Esteban M. Dominguez
LKLindsey N. Kent
Lindsey N. Kent
MSMichael J. Soares
Michael J. Soares
Establishment of the hemochorial uterine–placental interface requires exodus of trophoblast cells from the placenta and their transformative actions on the uterus, which represent processes critical for a successful pregnancy, but are poorly understood. We examined the involvement of CBP/p300-interacting transactivator with glutamic acid/aspartic acid-rich carboxyl-terminal domain 2 (CITED2) in rat and human trophoblast cell development. The rat and human exhibit deep hemochorial placentation. CITED2 was distinctively expressed in the junctional zone (JZ) and invasive trophoblast cells of the rat. HomozygousCited2gene deletion resulted in placental and fetal growth restriction. SmallCited2null placentas were characterized by disruptions in the JZ, delays in intrauterine trophoblast cell invasion, and compromised plasticity. In the human placentation site, CITED2 was uniquely expressed in the extravillous trophoblast (EVT) cell column and importantly contributed to the development of the EVT cell lineage. We conclude that CITED2 is a conserved regulator of deep hemochorial placentation.

14 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
VSVinay Shukla
Vinay Shukla
AIAyelen Moreno Irusta
Ayelen Moreno Irusta
KVKaela Varberg
Kaela Varberg
MKMarija Kuna
Marija Kuna
KIKhursheed Iqbal
Khursheed Iqbal
MSMichael J. Soares
Michael J. Soares
Trophoblast stem (TS) cells have the unique capacity to differentiate into specialized cell types, including extravillous trophoblast (EVT) cells. EVT cells invade into and transform the uterus where they act to remodel the vasculature facilitating the redirection of maternal nutrients to the developing fetus. Disruptions in EVT cell development and function are at the core of pregnancy-related disease. WNT-activated signal transduction is a conserved regulator of morphogenesis of many organ systems, including the placenta. In human TS cells, activation of canonical WNT signaling is critical for maintenance of the TS cell stem state and its downregulation accompanies EVT cell differentiation. We show that aberrant WNT signaling undermines EVT cell differentiation. Notum, palmitoleoyl-protein carboxylesterase (NOTUM), a negative regulator of canonical WNT signaling, was prominently expressed in first trimester EVT cells developing in situ and upregulated in EVT cells derived from human TS cells. Furthermore, NOTUM was required for human TS cell differentiation to EVT cells. Activation of NOTUM in EVT cells is driven, at least in part, by endothelial PAS domain 1 (also called hypoxia-inducible factor 2 alpha). Collectively, our findings indicate that canonical WNT signaling is essential for maintenance of human trophoblast cell stemness and prevention of human TS cell differentiation. Downregulation of canonical WNT signaling via the actions of NOTUM is required for EVT cell differentiation. SIGNIFICANCE Extravillous trophoblast (EVT) cells play a critical role in transforming the uterine environment into a supportive organ facilitating embryonic/fetal development. Insufficient EVT cell-dependent uterine transformation can lead to obstetrical complications, including early pregnancy loss, preeclampsia, intrauterine growth restriction, and preterm birth. These complications carry a significant burden of morbidity and mortality for both the mother and the fetus. Notum, palmitoleoyl-protein carboxylesterase, a WNT signaling antagonist, is involved in promoting and maintaining EVT cell differentiation. This process is essential for the proper development of the placenta and is crucial for a healthy pregnancy.

17 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MKMarija Kuna
Marija Kuna
PDPramod Dhakal
Pramod Dhakal
KIKhursheed Iqbal
Khursheed Iqbal
EDEsteban M. Dominguez
Esteban M. Dominguez
LKLindsey N. Kent
Lindsey N. Kent
MSMichael J. Soares
Michael J. Soares
Establishment of the hemochorial uterine-placental interface requires exodus of trophoblast cells from the placenta and their transformative actions on the uterus, which represent processes critical for a successful pregnancy, but are poorly understood. We examined the involvement of CBP/p300-interacting transactivator with glutamic acid/aspartic acid-rich carboxyl terminal domain 2 ( CITED2 ) in rat and human trophoblast cell development. The rat and human exhibit deep hemochorial placentation. CITED2 was distinctively expressed in the junctional zone and invasive trophoblast cells of the rat. Homozygous Cited2 gene deletion resulted in placental and fetal growth restriction. Small Cited2 null placentas were characterized by disruptions in the junctional zone, delays in intrauterine trophoblast cell invasion, and compromised plasticity. In the human placentation site, CITED2 was uniquely expressed in the extravillous trophoblast ( EVT ) cell column and importantly contributed to development of the EVT cell lineage. We conclude that CITED2 is a conserved regulator of deep hemochorial placentation. Significance Statement: The process of establishing the uterine-placental interface is a poorly understood tissue re-engineering event that involves genetically foreign trophoblast cells breaching the immunologically secure uterus. When optimal, mother and fetus thrive, whereas failures represent the root cause of life-threatening diseases of pregnancy. CBP/p300-interacting transactivator with glutamic acid/aspartic acid-rich carboxyl terminal domain 2 ( CITED2 ) is a transcriptional co-regulator with a conspicuous presence in trophoblast cell lineages infiltrating the uterine parenchyma. CITED2 helps coordinate the differentiation of rat and human trophoblast cells into invasive/extravillous trophoblast cells capable of transforming the uterus. These actions ensure requisite placental development and adaptations to physiological stressors. CITED2 exemplifies a conserved regulator of transcriptional events essential for establishing the uterine-placental interface.

16 June 2026 in Biology of Reproduction
Verified
Journal Article
Closed access
MKMarija Kuna
Marija Kuna
KIKhursheed Iqbal
Khursheed Iqbal
KGKelly Gorman
Kelly Gorman
LBLaszlo Balint
Laszlo Balint
KKKeisuke Kozai
Keisuke Kozai
MSMichael J. Soares
Michael J. Soares
Adrenomedullin (ADM) is a peptide hormone with a broad spectrum of actions on vascular smooth muscle, endothelial cells, and immune cells. These ADM cellular targets are prominent constituents of the uterine-placental interface that undergo structural and functional transformation during pregnancy. To explore the biology of ADM at the uterine-placental interface, we examined ADM expression using in situ hybridization and generated and characterized an ADM mutant rat model using CRISPR-Cas9-mediated genome editing. At midgestation, Adm was prominently expressed in trophoblast giant cells. Adm expression shifted to the mesometrial uterus as gestation progressed. A germline Adm mutant model was generated. Adm heterozygous males and females were fertile; however, Adm heterozygous intercrosses did not generate live Adm null rats. Adm null fetal-placental sites were viable until gestation day (gd) 15.5. Viable null fetuses were not identified after gd 15.5. Fetal and placental growth restriction were evident on gd 13.5. On gd 15.5 some Adm null placentas exhibited prominent hemorrhagic regions, whereas both hemorrhage and edema were evident in gd 15.5 Adm null fetuses. Our results indicate that ADM serves as a regulator of placental and fetal development.

22 August 2026 in Human Reproduction
Verified
Journal Article
Closed access
RSRegan L Scott
Regan L Scott
AMAyelen Moreno-Irusta
Ayelen Moreno-Irusta
KVKaela Varberg
Kaela Varberg
MKMarija Kuna
Marija Kuna
DJDavid K Johnson
David K Johnson
MSMichael J. Soares
Michael J. Soares
STUDY QUESTION: What is the contribution of cyclin-dependent kinase inhibitor 1C (CDKN1C) to the regulation of extravillous trophoblast (EVT) cell differentiation and function? SUMMARY ANSWER: Cell cycle regulators CDKN1C, cyclin-dependent kinase 7 (CDK7), and cyclin E1 (CCNE1) contribute to the development of a healthy placenta by promoting trophoblast stem (TS) cell differentiation to the invasive EVT cell lineage. WHAT IS KNOWN ALREADY: Early in gestation, cytotrophoblast cells expand and then differentiate into terminal cell lineages, including EVT cells, which invade into uterine tissue and facilitate redirection of maternal resources to the fetus. Cyclin-dependent kinase inhibitor 1C (CDKN1C) is a cell cycle regulator implicated in placental development. STUDY DESIGN, SIZE, DURATION: In this study, we used control versus gene-silenced human trophoblast stem cells to assess mechanisms regulating human TS cell differentiation to the EVT cell lineage. An 8-day EVT cell differentiation protocol was utilized. RNA sequencing data include n = 3 for control EVT cells and n = 3 for gene-silenced cells. Assessment of cell counts, DNA content, qPCR, and migration assays were performed with between n = 3 and n = 6. PARTICIPANTS/MATERIALS, SETTING, METHODS: In situ hybridization was used to evaluate CDKN1C, CDK7, and CCNE1 transcript expression in human placental tissue sections. A human trophoblast stem cell model was utilized to assess the contributions of CDKN1C, CDK7, and CCNE1 to EVT cell development. Gene perturbation was achieved through lentiviral delivery of short-hairpin RNAs to XY (CT29) and XX (CT27) human TS cell lines. Characterization of cell models and effects of gene silencing were measured by assessing cell morphology and number, reverse transcriptase-quantitative polymerase chain reaction, western blotting, flow cytometry, and co-immunoprecipitation. MAIN RESULTS AND THE ROLE OF CHANCE: CDKN1C was expressed in EVT cells of the placenta and in EVT cells derived from TS cells. Disruption of CDKN1C in TS cells affected cell proliferation, morphology, DNA content, migration, and transcript profiles. CDKN1C is a known modulator of CDK–CCN complexes. CDK7 and CCNE1 were prominently expressed in EVT cells of the placenta and in EVT cells derived from TS cells. CDKN1C was also shown to physically interact with CDK7 and CCNE1. Loss of CDK7 or CCNE1 impaired EVT cell differentiation. LARGE SCALE DATA: RNA-seq datasets are available at the Gene Expression Omnibus database under accession number GSE316875. LIMITATIONS, REASONS FOR CAUTION: In vitro experiments were used to evaluate contribution of cell cycle regulators to EVT cell development. Therefore, these methods do not completely recapitulate the in vivo cell environment. WIDER IMPLICATIONS OF THE FINDINGS: Collectively, these findings demonstrate the importance CDKN1C in regulating EVT cell differentiation and link its actions, at least in part, to CDK7 and CCNE1. FUNDING: Supported by an NIH F31predoctoral fellowship to RLS (HD104495), an NIH K99/R00 grants to KMV (HD107262) and AMI (HD115834), P20GM113117 to DKJ, NIH grants (HD020676, HD105734, HD112559), The Sosland Foundation, and the Donald C. Johnson Research Endowment Fund. DISCLOSURES: No disclosures to report.